HPV is also associated with genital
warts and vulvar, vaginal, penile, anal and oropharyngeal cancers.
«Based on epidemiological studies, the 9vHPV vaccine could prevent approximately 90 percent of cervical cancer, 90 percent of HPV - related
vulvar and vaginal cancer, 70 to 85 percent of high - grade cervical disease in females,
and approximately 90 percent of HPV - related anal cancer
and genital
warts in males
and females worldwide,» explained Anna R. Giuliano, Ph.D., Director of the Center for Infection Research in Cancer at Moffitt.